Xian-Rang Song
Overview
Explore the profile of Xian-Rang Song including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
188
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bi Z, Qiu P, Yang T, Chen P, Song X, Zhao T, et al.
Front Oncol
. 2022 Nov;
12:982011.
PMID: 36439466
Purpose: The traditional shrinkage classification modes might not suitable for guiding breast conserving surgery (BCS) after neoadjuvant therapy (NAT). Aim was to explore the modified shrinkage classification modes to guide...
2.
Bi Z, Qiu P, Zhang Y, Song X, Chen P, Xie L, et al.
Front Oncol
. 2021 Dec;
11:779140.
PMID: 34938660
Purpose: The study aimed to explore whether the expression of lncRNAs in primary tumors could predict nodal efficacy after neoadjuvant therapy (NAT) for HER2+ breast cancer. Methods: Total RNA was...
3.
Chen P, Zhao T, Bi Z, Zhang Z, Xie L, Liu Y, et al.
Future Oncol
. 2021 Apr;
17(19):2449-2460.
PMID: 33878939
The purpose was to integrate clinicopathological and laboratory indicators to predict axillary nodal pathologic complete response (apCR) after neoadjuvant therapy (NAT). The pretreatment clinicopathological and laboratory indicators of 416 clinical...
4.
Yu M, Song X, Zhao Y, Dong X, Niu L, Zhang Z, et al.
Front Oncol
. 2021 Mar;
11:618967.
PMID: 33777763
Background: Exosomes derived from cancer cells encapsulate various kinds of tumor-specific molecules and thus can interact with adjacent or distant cells to mediate information exchange. Long non-coding RNAs (lncRNAs) in...
5.
Wang X, Bi Z, Liang Y, Zhou P, Chen P, Qiu P, et al.
Future Oncol
. 2020 Dec;
17(4):359-361.
PMID: 33305595
No abstract available.
6.
Bi Z, Chen P, Liu Y, Zhao T, Sun X, Song X, et al.
Breast Cancer Res Treat
. 2020 Aug;
184(2):397-405.
PMID: 32776291
Background And Purpose: Paclitaxel-based regimens are widely used in the neoadjuvant therapy (NAT) of breast cancer. The purpose is to analysis the efficacy and adverse events (AEs) among common paclitaxel...
7.
Zhang Z, Song X, Xie L, Wang K, Tang Y, Yu M, et al.
Exp Biol Med (Maywood)
. 2020 Aug;
245(16):1428-1436.
PMID: 32741216
The high mortality of non-small cell lung cancer (NSCLC) is mainly because the cancer has progressed to a more advanced stage before diagnosis. If NSCLC can be diagnosed at early...
8.
Bi Z, Chen P, Song X, Wang Y
Future Oncol
. 2020 May;
16(21):1489-1491.
PMID: 32447966
No abstract available.
9.
Bi Z, Chen P, Song X, Wang Y
Gland Surg
. 2020 May;
9(2):430-436.
PMID: 32420269
In addition to axillary lymph node (ALN), internal mammary lymph node (IMLN) could also provide important prognostic information. In this paper, we will introduce a case of breast cancer patient...
10.
Cong B, Sun X, Song X, Liu Y, Zhao T, Cao X, et al.
Oncotarget
. 2016 Jul;
7(30):47526-47535.
PMID: 27374088
An appropriate receptor-targeted tracer for sentinel lymph node biopsy (SLNB) was prepared. We combined the fluorescence tracer (Indocyanine green, ICG) with Rituximab (a chimeric human/murine monoclonal antibody targeting the CD20...